Security key
52886N117
Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW)
CUSIP: 52886N117
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / *W EXP 01/14/202
- Total 13F shares
- 666,881
- Total 13F value
- $1,204,000
- Share change
- +76,627
- SEC-reported price per share
- $1.51
- Number of holders
- 5
- Value change
- +$114,724
- Number of buys
- 2
Report period
Q4 2021
Institutions
5
Top holders
5
LEXXW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Lexaria Bioscience Corp. SEC filings
Lexaria Bioscience Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52886N117
Recent filing periods:
Ownership snapshot
Top reported holders of LEXXW - Lexaria Bioscience Corp. - *W EXP 01/14/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Invenomic Capital Managem...
Disclosed value leader
Invenomic Capital Managem...
Comparable rows
0/12
Latest evidence
30 Sep 2021
13F
Highest disclosed value: $2,206,000
12 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
Invenomic Capital Management LP has the largest disclosed position value at $2.21M.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Invenomic Capital Management LP's linked filing trail.
Disclosed position value
Top 5
Invenomic Capital Management LP
$2.21M
SABBY MANAGEMENT, LLC
$699K
BOOTHBAY FUND MANAGEMENT, LLC
$494K
GEODE CAPITAL MANAGEMENT, LLC
$306K
VANGUARD GROUP INC
$193K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Invenomic Capital Management LP |
13F
Company
|
—
denominator unverified
|
$2,206,000
352,419 shares
|
— | 30 Sep 2021 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$699,000
332,971 shares
|
— | 30 Sep 2021 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$494,000
78,950 shares
|
— | 30 Sep 2021 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$306,000
49,002 shares
|
— | 30 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$193,000
30,834 shares
|
— | 30 Sep 2021 |
| CVI Holdings, LLC |
13F
Company
|
—
denominator unverified
|
$95,000
45,000 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
666,881
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q4 2025 Across Filers
Q4 2025 holders
2
Q4 2021 holders
5
Holder diff
3
| Investor | Q4 2025 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend